News Release

06/08/2017
Information
Beijing Continent Announces a Business Collaboration with Inceptua Clinical Services for Providing Drug Development Services to International Pharmaceutical Companies
05/23/2017
Information
Dr. Ying Luo will be giving a speech at 15th Annual Discovery on Target
05/15/2017
Information
Notice of Investigational New Drug (IND) Application Updates
05/10/2017
Event Calendar
Dr. Ying Luo will participate as panelist in the healthcare session of Japan-China Leadership Program
01/06/2017
Information
New Year Greetings
12/06/2016
Information
Notice of Ranking 119th in the 15th Deloitte Touche Tohmatsu Limited Asia Pacific Technology Fast 500, A Ranking Program of Fastest-Growing Technology Companies
11/25/2016
Information
Asia Business Leaders Awards 2016 ceremony
11/14/2016
Event Calendar
Asia Business Leaders Awards 2016 ceremony
10/27/2016
Information
GNI Group Announces Acquisition of Additional Land by Beijing Continent for Expansion of API Manufacturing Facilities
10/27/2016
Information
Shanghai Genomics Announces A Collaboration With TOKO on Healthcare Products
10/19/2016
Information
Notice of Ranking 5th in the 14th Deloitte Touche Tohmatsu LLC Japan Technology Fast50, A Ranking Program of Fastest-Growing Technology Companies
09/21/2016
Information
The article regarding Pirfenidone has been published on Nature.com Scientific Reports
09/09/2016
Information
Dr. Ying Luo, President and CEO of GNI Group Ltd., has been selected as a finalist for Asia Business Leaders Awards 2016
09/01/2016
Information
the 5th China Interstitial Lung Disease Conference
08/18/2016
Information
Shift to Direct Marketing Model for Etuary® Sales by Beijing Continent Pharmaceutical Co., Ltd.